Deep understanding of the interaction between thienorphine and UDP-glucuronosyltransferase (UGT) isoforms

Thienorphine has been demonstrated to be a potent, long-acting partial opioid agonist. It is being developed as a good candidate to treat opioid dependence. The thienorphine’s glucuronide was detected after thienorphine was incubated with human liver microsomes (HLMs). Recombinant UGT isoforms screening experiment and enzyme kinetic study showed that UGT1A1 completely contributed to the glucuronidation of thienorphine. Among the tested UGT isoforms, UGT1A3 and UGT2B7 were inhibited by thienorphine, with other UGT isoforms negligibly influenced. The inhibition type is competitive, and inhibition kinetic parameters (Ki) were 1.65 and 5.27 μM for UGT1A3 and UGT2B7, respectively. However, due to low plasma concentration of thienorphine, in vivo drug–drug interaction might not occur.

[1]  Guangbo Ge,et al.  Identification of UDP-glucuronosyltransferase isoforms involved in hepatic and intestinal glucuronidation of phytochemical carvacrol , 2012, Xenobiotica; the fate of foreign compounds in biological systems.

[2]  Guangbo Ge,et al.  Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9 , 2012, Xenobiotica; the fate of foreign compounds in biological systems.

[3]  M. Finel,et al.  Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms , 2012, Drug Metabolism and Disposition.

[4]  Werner Siegmund,et al.  Clarithromycin Is Absorbed by an Intestinal Uptake Mechanism That Is Sensitive to Major Inhibition by Rifampicin: Results of a Short-Term Drug Interaction Study in Foals , 2012, Drug Metabolism and Disposition.

[5]  Guangbo Ge,et al.  Investigation of UDP‐glucuronosyltransferases (UGTs) Inhibitory Properties of Carvacrol , 2012, Phytotherapy research : PTR.

[6]  Yan-Yan Zhang,et al.  Bioactivation of herbal constituents: simple alerts in the complex system , 2011, Expert opinion on drug metabolism & toxicology.

[7]  M. Ratain,et al.  Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors. , 2011, British journal of clinical pharmacology.

[8]  Guangbo Ge,et al.  Reversible inhibition of four important human liver cytochrome P450 enzymes by diethylstilbestrol. , 2011, Die Pharmazie.

[9]  T. Tracy,et al.  Correlation between Bilirubin Glucuronidation and Estradiol-3-Gluronidation in the Presence of Model UDP-Glucuronosyltransferase 1A1 Substrates/Inhibitors , 2011, Drug Metabolism and Disposition.

[10]  L. Yang,et al.  Strong inhibitory effect of medroxyprogesterone acetate (MPA) on UDP-glucuronosyltransferase (UGT) 2B7 might induce drug-drug interactions. , 2010, Pharmazie.

[11]  Yan-Yan Zhang,et al.  Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes , 2010, Phytotherapy research : PTR.

[12]  Yan-Yan Zhang,et al.  Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction. , 2010, British journal of clinical pharmacology.

[13]  R. Fujiwara,et al.  Expression of UGT1A and UGT2B mRNA in Human Normal Tissues and Various Cell Lines , 2008, Drug Metabolism and Disposition.

[14]  Zhen-qing Zhang,et al.  Simultaneous determination of thienorphine and its active metabolite thienorphine glucuronide in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic studies. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[15]  Z. Gong,et al.  Thienorphine Is a Potent Long-Acting Partial Opioid Agonist: A Comparative Study with Buprenorphine , 2006, Journal of Pharmacology and Experimental Therapeutics.

[16]  J. Miners,et al.  SELECTIVITY OF SUBSTRATE (TRIFLUOPERAZINE) AND INHIBITOR (AMITRIPTYLINE, ANDROSTERONE, CANRENOIC ACID, HECOGENIN, PHENYLBUTAZONE, QUINIDINE, QUININE, AND SULFINPYRAZONE) “PROBES” FOR HUMAN UDP-GLUCURONOSYLTRANSFERASES , 2006, Drug Metabolism and Disposition.

[17]  B. Zhong,et al.  Synthesis and Characterization of Thienorphine and Its Glucuronide Conjugate. , 2005 .

[18]  C. Guillemette,et al.  Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. , 2005, Pharmacogenetics and genomics.

[19]  Tony K L Kiang,et al.  UDP-glucuronosyltransferases and clinical drug-drug interactions. , 2005, Pharmacology & therapeutics.

[20]  M. Ratain,et al.  Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[21]  C. Parini,et al.  Selective δ opioid receptor agonists for inflammatory and neuropathic pain , 2001 .

[22]  J. Ritter.  Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. , 2000, Chemico-biological interactions.

[23]  D. Zimmerman,et al.  Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents. , 1990, Journal of medicinal chemistry.

[24]  J. Gerin,et al.  Characterization of hepatitis B virus (Dane particle). , 1980 .

[25]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[26]  M. Finel,et al.  Characterization of hepatic and intestinal glucuronidation of magnolol: application of the RAF approach to decipher the contributions of multiple UGT isoforms , 2011 .

[27]  曹云峰,et al.  Identification of Cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline and assessment of its herb-drug interactions , 2011 .